Frequently Asked Questions
The market is segmented based on Global Excoriation (Skin-picking) Disorder Market, By Treatment (Antidepressants, Anticonvulsants, Antipsychotics, Cognitive-behavioural Therapy (CBT), Others), Diagnosis (Physical Examination, Others), Dosage (Tablet, Injection, Others), Route of Administration (Oral, Intravenous, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Industry Trends and Forecast to 2030.
.
The Global Excoriation Skin Picking Disorder Market size was valued at USD 657.58 USD Million in 2022.
The Global Excoriation Skin Picking Disorder Market is projected to grow at a CAGR of 5.8% during the forecast period of 2023 to 2030.
The major players operating in the market include GlaxoSmithKline, Pfizer, AstraZeneca, Johnson & Johnson, Bristol Myers Squibb, Sandoz International, Apotex, Mylan, H. Lundbeck, Allergan, Sanofi, Merck Sharp & Dohme, Teva Pharmaceutical Industries, Alkermes, Takeda Pharmaceutical Company, OPKO Health, Intra Cellular Therapies, Janssen Pharmaceuticals, Lupin, Novartis, Bausch Health Companies, Eli Lilly and Company, Sumitomo Dainippon Pharma, AbbVie, Dr. Reddy's Laboratories.
The market report covers data from the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
